MimiVax
Buffalo, NY
MimiVax is a privately-held, clinical-stage biotechnology company that focuses on the development and commercialization of immunotherapeutic vaccines and targeted therapies for the treatment of cancer. Its vaccines use survivin-targeting technology to target a cell-survival protein present in most cancers that enable healthcare providers to cure their patients. The company was founded in 2012 and is headquartered in Buffalo, New York.
mimivax.comCompany Details
Founded
- 2012
Employees
- Between 2 - 10 employees
Raised
- $16,550,000
Headquarters Location
- Buffalo, NY
Public
- No
Acquired
- No
CEO
- Michael Ciesielski
Founders
- Robert Fenstermaker
Company Collections
These are collections MimiVax is a part of. Click on the collection name to view similar companies.